XpresSpa Group Has Signed a Deal for a New XpresCheck™ COVID-19 Testing Facility at Salt Lake City International Airport

News Release Details

XpresSpa Group Has Signed a Deal for a New XpresCheck™ COVID-19 Testing Facility at Salt Lake City International Airport

Expected to Commence Operations by mid-January

SALT LAKE CITY, Dec. 22, 2020 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced that it has signed a lease amendment for an XpresCheck™ COVID-19 testing facility at Salt Lake City International that is expected to be fully operational by mid-January.

XpresCheck will be building a pop-up facility in their existing XpresSpa location at Concourse A, post-security. The Company’s pop-up building methodology enables XpresSpa to accelerate XpresCheck’s rollout to additional airports at a lower cost than the original modular constructed facilities. This facility will host four separate testing rooms with an anticipated capacity to administer over 250 tests per day. COVID-19 testing options will include the Rapid Molecular COVID-19 Test and the Polymerase Chain Reaction (PCR) Test.

Doug Satzman, XpresSpa CEO, stated, "We are eager to launch XpresCheck at Salt Lake City International Airport, where will install our pop up prototype in one of our exiting XpresSpa locations. As the virus continues to spread, we are prepared to address the challenge through reliable and efficient testing that will help provide an extra layer of security and comfort to passengers and airline employees. Our expansion of COVID-19 testing within airports also supports our long-term goal to become the leading brand in the rapidly emerging travel health and wellness category.”

About XpresSpa Group, Inc. 

XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading global health and wellness holding company. XpresSpa Group’s core asset, XpresSpa, is a leading airport retailer of spa services and related health and wellness products, with 50 locations in 25 airports globally. Through its XpresTest, Inc. subsidiary, the Company also provides COVID-19 screening and testing, rapid testing services for other communicable diseases that include influenza, mononucleosis and group A streptococcus, and flu vaccination services under its XpresCheck™ brand. Current XpresCheck Wellness Centers include JFK International Airport, Newark Liberty International Airport, Logan International Airport, Phoenix Sky Harbor International Airport, and Denver International Airport. To learn more about XpresSpa Group, visit: www.XpresSpaGroup.com. To learn more about XpresSpa, visit www.XpresSpa.com. To learn more about XpresCheck, visit www.XpresCheck.com.

About Salt Lake City International Airport

The Salt Lake City International Airport (SLC) is operated and managed by the Salt Lake City Department of Airports, a department of Salt Lake City Corporation. Prior to the pandemic, SLC was the 23rd busiest airport in North America and the 85th busiest in the world. More than 370 flights departed daily to 99 nonstop destinations. SLC is undergoing a $4.1 billion redevelopment program, the first phase of which opened in fall of 2020.

Forward-Looking Statements

This press release may contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. In particular, these statements include, without limitation, statements about our expectations relating to our new XpresCheck™ concept, being able to expand testing to other communicable diseases as well as administer vaccinations for the seasonal flu, our positioning to be part of the national rollout of various COVID-19 vaccinations as they become available, the degree to which our public testing model assists passengers meet testing requirements in select states and countries, our ability to identify and gain access to the latest and best COVID-19 testing methodologies and equipment, and our ability further expand our initial sites and our overall ability to manage the regulatory challenges associated with this business line.  Forward-looking statements relating to expectations about future results or events are based upon information available to XpresSpa Group as of today's date and are not guarantees of the future performance of the company, and actual results may vary materially from the results and expectations discussed. Additional information concerning these and other risks is contained in XpresSpa Group’s most recently filed Annual Report on Form 10-K, Quarterly Report on Form 10-Q, recent Current Reports on Form 8-K and other Securities and Exchange Commission filings. All subsequent written and oral forward-looking statements concerning XpresSpa Group, or other matters and attributable to XpresSpa Group or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. XpresSpa Group does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof.

Investor Relations:
Raphael Gross
(203) 682-8253

Julie Ferguson
(312) 385-0098

Primary Logo

Source: XpresSpa Group, Inc.